1. Home
  2. ABUS vs WDH Comparison

ABUS vs WDH Comparison

Compare ABUS & WDH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABUS
  • WDH
  • Stock Information
  • Founded
  • ABUS 2005
  • WDH 2016
  • Country
  • ABUS United States
  • WDH China
  • Employees
  • ABUS N/A
  • WDH N/A
  • Industry
  • ABUS Biotechnology: Pharmaceutical Preparations
  • WDH Specialty Insurers
  • Sector
  • ABUS Health Care
  • WDH Finance
  • Exchange
  • ABUS Nasdaq
  • WDH Nasdaq
  • Market Cap
  • ABUS 670.3M
  • WDH 542.5M
  • IPO Year
  • ABUS N/A
  • WDH 2021
  • Fundamental
  • Price
  • ABUS $3.43
  • WDH $1.35
  • Analyst Decision
  • ABUS Strong Buy
  • WDH
  • Analyst Count
  • ABUS 4
  • WDH 0
  • Target Price
  • ABUS $5.50
  • WDH N/A
  • AVG Volume (30 Days)
  • ABUS 610.0K
  • WDH 170.2K
  • Earning Date
  • ABUS 07-31-2025
  • WDH 06-05-2025
  • Dividend Yield
  • ABUS N/A
  • WDH 2.39%
  • EPS Growth
  • ABUS N/A
  • WDH 118.23
  • EPS
  • ABUS N/A
  • WDH 0.15
  • Revenue
  • ABUS $6,403,000.00
  • WDH $388,729,415.00
  • Revenue This Year
  • ABUS $3.35
  • WDH N/A
  • Revenue Next Year
  • ABUS N/A
  • WDH $5.49
  • P/E Ratio
  • ABUS N/A
  • WDH $8.94
  • Revenue Growth
  • ABUS N/A
  • WDH 3.35
  • 52 Week Low
  • ABUS $2.71
  • WDH $0.97
  • 52 Week High
  • ABUS $4.73
  • WDH $1.57
  • Technical
  • Relative Strength Index (RSI)
  • ABUS 50.84
  • WDH 45.37
  • Support Level
  • ABUS $3.46
  • WDH $1.29
  • Resistance Level
  • ABUS $3.65
  • WDH $1.49
  • Average True Range (ATR)
  • ABUS 0.12
  • WDH 0.06
  • MACD
  • ABUS -0.00
  • WDH -0.02
  • Stochastic Oscillator
  • ABUS 35.29
  • WDH 25.00

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About WDH Waterdrop Inc. (each representing the right to receive 10)

Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.

Share on Social Networks: